Faes Farma (Spain) Performance
| FAE Stock | EUR 5.29 0.04 0.75% |
On a scale of 0 to 100, Faes Farma holds a performance score of 22. The firm shows a Beta (market volatility) of 0.17, which means not very significant fluctuations relative to the market. As returns on the market increase, Faes Farma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Faes Farma is expected to be smaller as well. Please check Faes Farma's downside deviation, total risk alpha, value at risk, as well as the relationship between the information ratio and treynor ratio , to make a quick decision on whether Faes Farma's price patterns will revert.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Faes Farma SA are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical and fundamental indicators, Faes Farma exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 91.2 M | |
| Total Cashflows From Investing Activities | -83.5 M |
Faes |
Faes Farma Relative Risk vs. Return Landscape
If you would invest 440.00 in Faes Farma SA on October 12, 2025 and sell it today you would earn a total of 89.00 from holding Faes Farma SA or generate 20.23% return on investment over 90 days. Faes Farma SA is generating 0.3029% of daily returns assuming 1.0484% volatility of returns over the 90 days investment horizon. Simply put, 9% of all stocks have less volatile historical return distribution than Faes Farma, and 94% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Faes Farma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Faes Farma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Faes Farma SA, and traders can use it to determine the average amount a Faes Farma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.289
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | FAE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.05 actual daily | 9 91% of assets are more volatile |
Expected Return
| 0.3 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.29 actual daily | 22 78% of assets perform better |
Based on monthly moving average Faes Farma is performing at about 22% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Faes Farma by adding it to a well-diversified portfolio.
Faes Farma Fundamentals Growth
Faes Stock prices reflect investors' perceptions of the future prospects and financial health of Faes Farma, and Faes Farma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Faes Stock performance.
| Return On Equity | 0.16 | |||
| Return On Asset | 0.1 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.22 % | |||
| Current Valuation | 1 B | |||
| Shares Outstanding | 306 M | |||
| Price To Earning | 20.64 X | |||
| Price To Book | 1.86 X | |||
| Price To Sales | 2.33 X | |||
| Revenue | 398.56 M | |||
| EBITDA | 110.38 M | |||
| Cash And Equivalents | 56.13 M | |||
| Cash Per Share | 0.20 X | |||
| Total Debt | 3.5 M | |||
| Debt To Equity | 5.30 % | |||
| Book Value Per Share | 1.89 X | |||
| Cash Flow From Operations | 79.64 M | |||
| Earnings Per Share | 0.27 X | |||
| Total Asset | 641.76 M | |||
About Faes Farma Performance
By analyzing Faes Farma's fundamental ratios, stakeholders can gain valuable insights into Faes Farma's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Faes Farma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Faes Farma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Faes Farma, S.A., a pharmaceutical company, researches, develops, produces, and commercializes pharmaceutical products and raw materials. Faes Farma, S.A. was founded in 1933 and is headquartered in Madrid, Spain. FAES FARMA operates under Medical Instruments Supplies classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 1264 people.Things to note about Faes Farma SA performance evaluation
Checking the ongoing alerts about Faes Farma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Faes Farma SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating Faes Farma's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Faes Farma's stock performance include:- Analyzing Faes Farma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Faes Farma's stock is overvalued or undervalued compared to its peers.
- Examining Faes Farma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Faes Farma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Faes Farma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Faes Farma's stock. These opinions can provide insight into Faes Farma's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Faes Stock analysis
When running Faes Farma's price analysis, check to measure Faes Farma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Faes Farma is operating at the current time. Most of Faes Farma's value examination focuses on studying past and present price action to predict the probability of Faes Farma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Faes Farma's price. Additionally, you may evaluate how the addition of Faes Farma to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |